Literature DB >> 12598611

Synergistic dopaminergic neurotoxicity of the pesticide rotenone and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease.

Hui-Ming Gao1, Jau-Shyong Hong, Wanqin Zhang, Bin Liu.   

Abstract

Parkinson's disease (PD) is characterized by a progressive degeneration of the nigrostriatal dopaminergic pathway resulting in movement disorders. Although its etiology remains unknown, PD may be the final outcome of interactions among multiple factors, including exposure to environmental toxins and the occurrence of inflammation in the brain. In this study, using primary mesencephalic cultures, we observed that nontoxic or minimally toxic concentrations of the pesticide rotenone (0.5 nm) and the inflammogen lipopolysaccharide (LPS) (0.5 ng/ml) synergistically induced dopaminergic neurodegeneration. The synergistic neurotoxicity of rotenone and LPS was observed when the two agents were applied either simultaneously or in tandem. Mechanistically, microglial NADPH oxidase-mediated generation of reactive oxygen species appeared to be a key contributor to the synergistic dopaminergic neurotoxicity. This conclusion was based on the following observations. First, inhibition of NADPH oxidase or scavenging of free radicals afforded significant neuroprotection. Second, rotenone and LPS synergistically stimulated the NADPH oxidase-mediated release of the superoxide free radical. Third and most importantly, rotenone and LPS failed to induce the synergistic neurotoxicity as well as the production of superoxide in cultures from NADPH oxidase-deficient animals. This is the first demonstration that low concentrations of a pesticide and an inflammogen work in synergy to induce a selective degeneration of dopaminergic neurons. Findings from this study may be highly relevant to the elucidation of the multifactorial etiology of PD and the discovery of effective therapeutic agents for the treatment of the disease.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12598611      PMCID: PMC6742266     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  91 in total

Review 1.  NADPH oxidases: novel therapeutic targets for neurodegenerative diseases.

Authors:  Hui-Ming Gao; Hui Zhou; Jau-Shyong Hong
Journal:  Trends Pharmacol Sci       Date:  2012-04-11       Impact factor: 14.819

Review 2.  Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases.

Authors:  Lisa M Kosloski; Duy M Ha; Jessica A L Hutter; David K Stone; Michael R Pichler; Ashley D Reynolds; Howard E Gendelman; R Lee Mosley
Journal:  J Neurochem       Date:  2010-05-26       Impact factor: 5.372

Review 3.  Neurodegenerative disorders: Parkinson's disease and Huntington's disease.

Authors:  S M Hague; S Klaffke; O Bandmann
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08       Impact factor: 10.154

4.  Heme oxygenase-1 exacerbates early brain injury after intracerebral haemorrhage.

Authors:  Jian Wang; Sylvain Doré
Journal:  Brain       Date:  2007-06       Impact factor: 13.501

Review 5.  Estrogen anti-inflammatory activity in brain: a therapeutic opportunity for menopause and neurodegenerative diseases.

Authors:  Elisabetta Vegeto; Valeria Benedusi; Adriana Maggi
Journal:  Front Neuroendocrinol       Date:  2008-04-29       Impact factor: 8.606

6.  Microglia enhance manganese chloride-induced dopaminergic neurodegeneration: role of free radical generation.

Authors:  Ping Zhang; Tamika A Wong; Kyle M Lokuta; Deanne E Turner; Kristina Vujisic; Bin Liu
Journal:  Exp Neurol       Date:  2009-03-05       Impact factor: 5.330

7.  Dietary fat intake, pesticide use, and Parkinson's disease.

Authors:  Freya Kamel; Samuel M Goldman; David M Umbach; Honglei Chen; Gina Richardson; Marie Richards Barber; Cheryl Meng; Connie Marras; Monica Korell; Meike Kasten; Jane A Hoppin; Kathleen Comyns; Anabel Chade; Aaron Blair; Grace S Bhudhikanok; G Webster Ross; J William Langston; Dale P Sandler; Caroline M Tanner
Journal:  Parkinsonism Relat Disord       Date:  2013-10-01       Impact factor: 4.891

8.  Protective effects of curcumin against rotenone and salsolinol-induced toxicity: implications for Parkinson's disease.

Authors:  Zakiya Qualls; Dwayne Brown; Carlana Ramlochansingh; Laura L Hurley; Yousef Tizabi
Journal:  Neurotox Res       Date:  2014-01       Impact factor: 3.911

9.  PGE2 EP1 receptor deletion attenuates 6-OHDA-induced Parkinsonism in mice: old switch, new target.

Authors:  Abdullah Shafique Ahmad; Takayuki Maruyama; Shuh Narumiya; Sylvain Doré
Journal:  Neurotox Res       Date:  2013-02-06       Impact factor: 3.911

10.  The class B scavenger receptor CD36 mediates free radical production and tissue injury in cerebral ischemia.

Authors:  Sunghee Cho; Eun-Mi Park; Maria Febbraio; Josef Anrather; Laibaik Park; Gianfranco Racchumi; Roy L Silverstein; Costantino Iadecola
Journal:  J Neurosci       Date:  2005-03-09       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.